Lepu Biopharma Co. Ltd. said Oct. 30 it won Chinese approval of a novel antibody-drug conjugate (ADC), Meiyouheng (becotatug ...

This data is encouraging as it reinforces the large and growing body of evidence indicating that certepetide can enhance the targeting, penetration, and effectiveness of therapeutic agents - in this ...

After Pfizer agreed to acquire weight-loss drug developer Metsera for $7.3 billion, Novo Nordisk swooped in with an ...

The deadline for required immunizations for Muscogee County School District is technically July 31, but schools allow a ...

Merck (MRK) on Tuesday announced an agreement under which funds managed by Blackstone (BX) Life Sciences will provide the New ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that the company has entered into an agreement to receive funds managed by Blackstone Life Sciences ...

(“Sintana ”) and Challenger Energy Group plc (“Challenger ”) earlier today, we have reached another milestone associated with our proposed all-share acquisition of Challenger. A Scheme Document in ...

Gary Hattersley, chief scientific officer at Nuvation Bio ( NUVB +1.36%), exercised and immediately sold 100,000 shares of Class A common stock in an open-market derivative transaction on October 27, ...

The actor is stepping back into the spotlight once again with his role in Rachel Sennott ‘s HBO series I Love LA, which ...

Students – and all manner of professionals – are tempted to outsource their thinking to AI, which threatens to undermine learning and credibility. A philosophy professor offers a solution.

The FDA has approved Blenrep with BVd as a third-line treatment for relapsed or refractory multiple myeloma.